Together, these results show that MKP1 mRNA expression is generally low in tumor samples, lower levels are associated with advanced glioma grade, but these low levels of MKP1 correlate with poor overall patient survival underlining the impact of MKP1 expression as an independent glioblastoma prognostic marker. This evidence concerns the gene DUSP1 and central nervous system cancer.